Omagap, Sammy D.

HRN: 28-24-66  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/06/2026
AMPICILLIN 500MG (VIAL)
01/06/2026
01/13/2026
IV
85mg
Q6hours
Neonatal Sepsis
Waiting Final Action 
01/06/2026
GENTAMICIN 40MG/ML, 2ML (AMP)
01/06/2026
01/13/2026
IV
17mg
Q24hours
Neonatal Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: